GTx Inc. to merge with Oncternal Therapeutics, end Memphis operations
Memphis-based biopharmaceutical company GTx Inc. and a San Diego-based biotech firm are planning a reverse merger that will end GTx’s Memphis operations.
Topics
GTx Inc. Oncternal TherapeuticsNatalie Pilgrim
Natalie Pilgrim is a Memphis native and a graduate of the University of Memphis. She is a digital producer for The Daily Memphian.
Kate Crawford
Associate editor Kate Crawford is a native Memphian and third-generation University of Memphis alumna.
Comments
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.